Everlight Solar: Voted One of Glassdoor’s Best Places to Work
Everlight Solar’s mission has always been to brighten the world with renewable energy while fostering a culture that empowers and inspires. They are thrilled to
Home
Page 500
Johnson Pope Welcomes Adam D. Kravatz to Its Healthcare Practice Group
Johnson Pope Bokor Ruppel & Burns, LLP is excited to announce that Adam D. Kravatz has joined the firm as an associate in its Healthcare Practice Group, further
AM Best Affirms Credit Ratings of Fubon Insurance Co., Ltd.
AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of Fubon Insurance Co., Ltd. (Fubon
RTS Gains Financing to Boost AI & Expand Waste Solutions in North America
Recycle Track Systems, Inc. (RTS), a pioneer in transforming waste and recycling management, proudly announces the closing of financing, raising over $40 million to drive innovation and
SPIE, Boston U Announce $1M Endowment for Grad Scholarships
The SPIE-Boston University Scholarship in Photonics will support graduate students and postdoctoral researchers at the university’s Photonics Center SPIE, the international society for optics and
Aviz & Keysight Showcase SONiC’s Readiness for AI Networks
Calling Current and Future SONiC Users: Sign Up Now for PlugFest to Receive Detailed Technical Quality Reports Tailored to Your Deployment Use Cases Across Multiple Switch Vendors.
Carbon capture project boosts sustainability in industrial sectors.
Innovative capture technology design enables key carbon capture and storage project in Norway to move forward SLB (NYSE: SLB) today announced that SLB Capturi, in
Merck, Eisai Update Phase 3 LEAP-015 Trial for GE Adenocarcinoma
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced results from the Phase 3 LEAP-015 trial evaluating
Innate Pharma Doses First Patient in Phase 1 Study of IPH4502
IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC conjugated to exatecan targeting Nectin-4 Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA)
Sphere Fluidics Unveils Cyto-Mine Chroma, Early Access Open
Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D Sphere Fluidics, a
Ikonisys Wins U.S. Patent for Automated Cancer Treatment Analysis
Regulatory News: Ikonisys Inc., a leader in advanced cell-based diagnostic solutions fully owned by ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), is proud to announce the
Corstasis Announces FDA Acceptance for Bumetanide Nasal Spray
PDUFA Target Action Date Set for September 14, 2025 Corstasis Therapeutics Inc. (www.corstasis.com), a clinical-stage MedTech pharmaceutical company developing innovative, practical therapies for fluid overload,
Engrain Announces Robust Support of Fee Transparency in SightMap
Leader in data visualization rolls out integrated support for all-in pricing within the company’s popular SightMap product Engrain, the market leader in interactive touring, mapping
LanzaTech Appoints Reyad Fezzani to Board of Directors
Fezzani’s three decades of global energy expertise and leadership in renewable energy development will bolster LanzaTech’s mission to globally deploy its leading carbon management technology
RFG Advisory Launches Refreshed Brand to Redefine Advisor Experience
Transformative suite of tools and concierge-level services reimagines traditional wealth management support for independent Advisors RFG Advisory (“RFG”), an innovator in the wealth management industry committed